Robert Hennessey was named president and chief executiveofficer of Collaborative Research Inc. of Waltham, Mass. He waspresident of Hennessey & Associates Ltd., a private consultingfirm specializing in strategy development and deal structuringin the biotechnology and pharmaceutical industries.
Cortech Inc. of Denver named Kenneth Lynn vice president ofbusiness development and general counsel and Bernard Dainavice president of human resources. Lynn was vice president,general counsel and corporate secretary for U.S. Bioscience Inc.Daina had a private consulting practice.
Genentech Inc. of South San Francisco, Calif., promoted ArthurLevinson and Richard Brewer to senior vice presidents.Levinson was vice president of research and Brewer was vicepresident of sales and marketing.
Agouron Pharmaceuticals Inc. of La Jolla, Calif., named NeilClendeninn vice president of clinical affairs. He was head of thechemotherapy section at Burroughs Wellcome Co.
R. Edward Branson was named vice president of manufacturingat Cephalon Inc. of West Chester, Pa. He was director of contractbiotechnology manufacturing at Baxter Biotech-Hyland Division.
CoCensys of Irvine, Calif., named William Schary vice presidentof regulatory affairs. He was vice president of New DrugServices Inc., a contract research company.
Sibia Inc. of San Diego named Ian McDonald director ofchemistry and Gail Gillenwater director of clinical studies.McDonald was a senior research scientist and group leader atMarion Merrell Dow Research Institute. Gillenwater wasmanaging director and director of clinical development at NDAResources. Sibia also elected to its board of directors BrianHenderson, president of the Salk Institute and FrederickRentschler, former president and chief executive officer atBeatrice Co. and Northwest Airlines and a trustee of the SalkInstitute.
(c) 1997 American Health Consultants. All rights reserved.